Start-Ups in High Throughput Screening
This article was originally published in Start Up
Companies in the new generation of screening technologies are stressing content as much as they're stressing speed, and one-stop shopping as much as focused expertise.
You may also be interested in...
SIDDCO is not your traditional drug discovery start-up, eking out an existence by trying to create partnerships around a single technology. SIDDCO has three specialty technologies--combinatorial chemistry, high-density miniaturized screening and multi-array plate screening--to serve its string of corporate partners.
Understanding what makes one compound a hit or a miss is important in figuring out how to improve a screen. BioReason offers intelligent software on a per client basis by incorporating both specifics about a particular screen and the company's human expertise, to create artificially intelligent programs.
BioArray solutions has developed an optically programmable array technology designed to perform thousands of different quantitative biomolecular assays in concert. It aims to monitor molecular binding events such as those between antigens and antibodies in immunoassays and pairs of DNA in hybridization assays.